T834-1305 Screening compound: 5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

T834-1305 Screening compound: 5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one
T834-1305 Screening compound: 5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T834-1305
5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T834-1305

Molecular Formula

C25H27N5O2 (C25 H27 N5 O2)

Compound Name

5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

IUPAC name

5-(2-methylpropyl)-2-[2-(pyridin-3-yl)piperidine-1-carbonyl]-4H5H-pyrazolo[15-a]quinoxalin-4-one

SMILES

CC(C)CN(c(cccc1)c1-n(c1c2)nc2C(N(CCCC2)C2c2cnccc2)=O)C1=O

InChI

InChI=1S/C25H27N5O2/c1-17(2)16-29-21-10-3-4-11-22(21)30-23(25(29)32)14-19(27-30)24(31)28-13-6-5-9-20(28)18-8-7-12-26-15-18/h3-4,7-8,10-12,14-15,17,20H,5-6,9,13,16H2,1-2H3/t20-/m0/s1

InChI Key

AYCVJTPKDSEHLX-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD29029358

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.397

Distribution Coefficient, logD

3.397

Water Solubility, LogSw

-3.50

Polar Surface Area

53.565

Acid Dissociation Constant (pKa)

22.03

Base Dissociation Constant (pKb)

2.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

T834-1305 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with T834-1305 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T834-1305?
Check Price and Availability of T834-1305, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T834-1305 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T834-1305
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T834-1305
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T834-1305 available by request